Límite 19 Oct 2022
Oferta Tecnológica
Ref.
TODE20211014002
A 3D-printed biomimetic tumour angiogenesis model
A German university offers a model that can be used to analyse tumour growth, tumour angiogenesis and therapeutic effects on a 3D-printed cell model. No animal tissue is needed. Therefore, this 3D-printed tumour model represents an ideal in-vitro-prescreening system for testing pharmaceuticals and diagnostics and might be able to circumvent or at least reduce the number of animal tests in drug development. Licensees are sought.